Researchers in Australia show in tests with lab mice that transplanted adult stem cells can provide long-term relief from chronic pain caused by nerve damage. . . . → Read More: Stem Cell Transplants Offer Nerve Pain Relief
|
|||||
|
|
An international health coalition is funding development of vaccines against the new coronavirus outbreak spreading quickly through China and to other countries. . . . → Read More: Int’l Group Funding Coronavirus Vaccines 
A company developing cancer therapies with stem cells from human placentas says FDA cleared its request to start a clinical trial of a treatment for brain cancer. . . . → Read More: FDA Clears Placenta Cell Brain Cancer Trial 
A systematic high-speed screen of more than 4,500 drugs on hundreds of cancer cell lines finds 49 approved drugs for a range of diseases are also able to treat cancer. . . . → Read More: Many Non-Cancer Drugs Found to be Cancer Fighters 
A bio-engineering lab developed a tiny edible tag from natural proteins that uniquely identifies individual doses of medicines to prevent counterfeiting. . . . → Read More: Protein Tags Devised to Stop Counterfeit Drugs 
UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy. . . . → Read More: UPMC to Invest $1 Billion in Medical Enterprises 
A gene therapy start-up is receiving an award resembling venture financing to advance its treatment for a rare inherited neuromuscular disorder to clinical trials. . . . → Read More: Venture Philanthropy Funds Rare Neuro Disease Trial 
A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs. . . . → Read More: New Biotech Aims to Bring Down Drug Prices 
Drug maker Boehringer Ingelheim is acquiring an antibody technology that blocks actions of a signaling protein associated with a range of fibrosis diseases. . . . → Read More: Pharma Gains Fibrosis Technology in $1B+ Deal  Comments are closed  Intellectual property  biomedical, biotechnology, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals, preclinical, university 
A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds Comments are closed Finance biomedical, biotechnology, equity, Europe, investment, licensing, life sciences, nanotechnology, pharmaceuticals, U.K., university, venture capital |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||